查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2047981

聚維酮市場－全球產業規模、佔有率、趨勢、機會與預測：依最終用途、銷售管道、地區和競爭格局分類，2021-2031年

Povidone Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End-Use Application, By Sales Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球聚維酮市場預計將從 2025 年的 11.2 億美元成長到 2031 年的 15.5 億美元，複合年成長率達到 5.56%。

聚維酮（化學名稱：聚乙烯吡咯烷酮）是一種用途廣泛的合成聚合物，主要用作製藥、個人護理和食品行業的粘合劑、成膜劑和穩定劑。全球學名藥產業的顯著擴張是推動市場成長的主要因素，該產業需要高純度輔料來製備有效的片劑並提高生物利用度。此外，在個人學名藥領域，消費者對利用聚維酮的固定化和乳化穩定性能的頭髮造型和護膚產品的需求不斷成長，也促進了這一成長趨勢。貿易數據也支持了這一龐大的工業消費，預計到2025年，印度等主要製造地的藥品出口額將達到304.6億美元，顯示全球對聚維酮等重要原料的需求持續旺盛。市場擴張的主要障礙在於輔料安全性和供應鏈透明度方面的監管合規性日益複雜。遵守嚴格的國際標準迫使製造商投入大量資金來開發先進的品管基礎設施和純化技術。因此，這種監管負擔成為了一種財務障礙，不僅擠壓了營業利潤率，而且使缺乏必要資源來吸收滿足嚴格的藥典要求所需增加的成本的小規模生產商難以進入市場。

市場概覽
預測期 2027-2031
市場規模：2025年 11.2億美元
市場規模：2031年 15.5億美元
複合年成長率：2026-2031年 5.56%
成長最快的細分市場 黏合劑
最大的市場 亞太地區

市場促進因素

聚維酮市場的主要成長要素是全球製藥業的持續擴張，該產業對用於固態劑型的高性能粘合劑和增溶劑的需求日益成長。隨著學名藥生產的不斷加速，製造商越來越依賴聚乙烯吡咯烷酮來提高難溶性活性成分（API）的生物利用度。主要輔料生產商的財務表現也印證了這項需求的激增。例如，亞什蘭公司報告稱，其製藥部門在2024會計年度第四季的銷售額成長了6%，這直接得益於銷售量的成長。為了滿足持續的產業需求，BASF等主要原料供應商正在維持充足的產能。該公司旗下的營養與護理部門（包括製藥原料）在2024年的外部銷售額達67.3億歐元。

同時，個人護理和化妝品行業對功能性成分日益成長的需求也顯著推動了市場成長。尤其值得一提的是，聚維酮作為頭髮定型劑和乳化穩定劑的效用十分廣泛。消費者越來越青睞高性能配方，促使品牌商採用具有卓越成膜性能且不留殘留物的多功能聚合物。這一強勁的消費趨勢在各大經濟體均有體現。根據歐洲化妝品協會（Cosmetics Europe）2025年7月發布的報告顯示，預計到2024年，歐洲化妝品和個人護理市場零售額將達到1039億歐元，這凸顯了該行業的韌性以及對關鍵配方聚合物的持續需求。

市場挑戰

全球聚維酮市場面臨的主要障礙之一是添加劑安全性和供應鏈透明度的監管合規要求日益複雜。為了符合更嚴格的國際藥典標準，製造商越來越需要投入大量資金用於先進的純化技術和完善的品管基礎設施。這種財務負擔顯著降低了營業利潤率，尤其對那些往往缺乏財力承擔這些飆升的遵循成本的小規模生產商影響尤為嚴重。因此，市場正在整合，只有財力雄厚的公司才能維持必要的生產標準，這限制了新企業的進入，扼殺了市場競爭力。

這些監管壓力正對聚維酮等關鍵輔料的消費產生切實的下游影響，而聚維酮對於片劑的黏合和提高生物利用度至關重要。近期產業統計數據凸顯了藥物開發平臺所面臨的壓力。例如，美國製藥商協會（PhRMA）報告稱，受近期監管變化的影響，到2025年，小分子化合物的研發投資將減少70%。研發活動的顯著減少將直接導致固態製劑中關鍵粘合劑的需求下降，進而阻礙聚維酮市場的整體銷售量成長。

市場趨勢

一個關鍵的市場趨勢是利用新一代水凝膠和奈米纖維開發創傷護理支架，這推動了對優碘和交聯PVP聚合物的特殊需求。隨著醫療專業人員日益尋求治療慢性潰瘍和術後感染的先進解決方案，製造商正將聚維酮碘融入複雜的基質中，旨在控制抗菌劑的釋放並有效管理水分。這標誌著從傳統消毒劑到生物活性癒合系統的策略轉變，其中聚合物作為關鍵支架成分發揮作用。這些尖端系統的商業性成功得益於關鍵醫療技術部門的強勁表現。例如，在感染控制和生物活性療法的廣泛應用推動下，史密斯醫療（Smith+Nephew）的先進傷口管理業務部門在2024年第四季實現了12.2%的核心銷售額成長。

另一個值得關注的趨勢是，該行業正轉向生物基前體和環保生產流程，積極重組供應鏈，以應對日益成長的碳足跡問題。供應商正在逐步淘汰用於生產聚維酮關鍵單體N-乙烯基吡咯烷酮的化石衍生原料，例如乙炔和甲醛，轉而使用可再生質能衍生的替代品。這種方法正獲得注重永續發展的製藥和化妝品品牌的支持，因為它能在不影響成品添加劑化學結構或監管狀態的前提下，有效降低其「生產階段」的碳排放。這一策略轉變帶來的正面環境影響是可以量化的。例如，BASF公司（BASF SE）的生質能平衡產品系列預計到2024年將減少約800萬公斤的二氧化碳排放，顯示永續化學中間體在工業領域的應用日益廣泛。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球聚維酮市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 最終用途類別（藥品、食品和飲料、個人護理和化妝品、黏合劑、其他）
    • 銷售管道（直銷、間接銷售）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美聚維酮市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲聚維酮市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區聚維酮市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：聚維酮在中東和非洲的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲聚維酮市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球聚維酮市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Ashland Inc
  • BASF SE
  • Boai NKY Pharmaceuticals Ltd
  • Glide Chem Private Limited
  • Hangzhou Motto Science & Technology Co. Ltd
  • JH Nanhang Life Sciences Co.,Ltd.
  • Sichuan Tianhua Chemical Group Co. Ltd.
  • Thermo Fisher Scientific Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27629

The global povidone market is projected to expand from USD 1.12 billion in 2025 to USD 1.55 billion by 2031, achieving a compound annual growth rate (CAGR) of 5.56%. Povidone, scientifically termed Polyvinylpyrrolidone, is a versatile synthetic polymer primarily serving as a binder, film former, and stabilizer across the pharmaceutical, personal care, and food sectors. This market's growth is fundamentally fueled by the significant expansion of the global generic drug industry, which requires high-purity excipients for effective tablet formulation and enhanced bioavailability. Additionally, the personal care sector contributes to this upward trend through increasing consumer demand for hair styling and skin care products that leverage povidone for its fixation and emulsion stabilization capabilities. This substantial industrial consumption is further corroborated by trade data, with pharmaceutical exports from major manufacturing hubs like India reaching USD 30.46 billion in 2025, thereby underscoring a consistent global need for crucial raw materials such as povidone. A considerable obstacle hindering the market's expansion stems from the intensifying complexity of regulatory compliance concerning excipient safety and supply chain transparency. Adherence to stringent international standards compels manufacturers to commit substantial capital towards developing advanced quality control infrastructure and purification technologies. This regulatory burden consequently acts as a financial barrier, squeezing operational margins and making market entry difficult for smaller producers who lack the necessary resources to absorb the increasing costs associated with meeting these rigorous pharmacopeial demands.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.12 Billion
Market Size 2031USD 1.55 Billion
CAGR 2026-20315.56%
Fastest Growing SegmentAdhesives
Largest MarketAsia Pacific

Market Driver

The primary catalyst for the povidone market is the ongoing expansion of the global pharmaceutical manufacturing sector, which demands high-performance binders and solubilizers for solid dosage forms. As the production of generic drugs continues to accelerate, manufacturers are increasingly dependent on polyvinylpyrrolidone to enhance the bioavailability of active pharmaceutical ingredients (APIs) that exhibit poor solubility. This escalating volume demand is clearly demonstrated by the financial outcomes of leading excipient producers; for instance, Ashland Inc. reported a six percent revenue growth in its pharmaceutical segment in the fourth quarter of fiscal year 2024, a direct result of increased sales volumes. To meet this sustained industrial requirement, major raw material suppliers like BASF SE are maintaining substantial operational capacities, with their Nutrition & Care segment, including pharmaceutical ingredients, reporting third-party sales of EUR 6.73 billion in 2024.

Concurrently, the increasing demand for functional ingredients within the personal care and cosmetics industries is also significantly propelling the market trajectory, especially for povidone's utility in hair styling fixatives and as emulsion stabilizers. Consumers are increasingly favoring high-performance formulations, which in turn compels brands to incorporate versatile polymers that deliver superior film-forming capabilities without leaving unwanted residue. This robust consumption trend is evident across major economic regions, with the European cosmetics and personal care market, as reported by Cosmetics Europe in July 2025, attaining a retail value of EUR 103.9 billion in 2024, thereby underscoring the sector's resilience and its ongoing need for crucial formulation polymers.

Market Challenge

A substantial barrier to the global povidone market is the growing complexity of regulatory compliance related to excipient safety and supply chain transparency. Manufacturers are increasingly obligated to allocate significant capital to advanced purification technologies and robust quality control infrastructure to adhere to stricter international pharmacopeial standards. This financial strain notably reduces operational margins, particularly impacting smaller-scale producers who often lack the financial capacity to absorb these escalating compliance expenditures. As a result, the market experiences a consolidation trend, with only well-capitalized entities capable of maintaining the requisite production standards, thereby restricting broader market entry and diminishing competitive vibrancy.

This regulatory pressure also creates a tangible downstream effect on the consumption of critical excipients such as povidone, which are essential for tablet binding and enhancing bioavailability. The strain on the pharmaceutical development pipeline is highlighted by recent industry figures; for instance, the Pharmaceutical Research and Manufacturers of America (PhRMA) reported a 70% decrease in small molecule development investments in 2025, following recent legislative and regulatory changes. This significant contraction in development activities directly translates into reduced demand for essential binders in solid dosage forms, consequently hindering the overall volume growth of the povidone market.

Market Trends

A significant market trend involves innovation in next-generation hydrogel and nanofiber wound care scaffolds, which is fueling specialized demand for povidone-iodine and cross-linked PVP polymers. As healthcare providers increasingly seek advanced solutions for managing chronic ulcers and surgical site infections, manufacturers are incorporating povidone into sophisticated matrices designed for controlled antiseptic release and effective moisture management. This represents a strategic pivot from conventional antiseptics towards bioactive healing systems, where the polymer functions as a vital scaffold component. The commercial success of these cutting-edge systems is underscored by the strong performance of leading medtech divisions; for example, Smith+Nephew's Advanced Wound Management business unit recorded an underlying revenue growth of 12.2 percent in the fourth quarter of 2024, propelled by the widespread adoption of infection management and bioactive therapies.

Another notable trend is the industry's transition towards bio-based precursors and green manufacturing processes, which is actively reshaping the supply chain in response to growing concerns over carbon footprints. Suppliers are progressively substituting fossil-based feedstocks, such as acetylene and formaldehyde, with renewable biomass-balanced alternatives for the production of N-vinylpyrrolidone, which is the crucial monomer for povidone. This approach effectively lowers the cradle-to-gate carbon impact of the finished excipient, without compromising its chemical structure or regulatory standing, thereby appealing to sustainability-focused pharmaceutical and cosmetic brands. The positive environmental impact of this strategic shift is quantifiable: BASF SE's portfolio of biomass-balanced products, for instance, prevented approximately 8 million kilograms of CO2 emissions in 2024, demonstrating the significant industrial adoption of sustainable chemical intermediates.

Key Market Players

  • Ashland Inc
  • BASF SE
  • Boai NKY Pharmaceuticals Ltd
  • Glide Chem Private Limited
  • Hangzhou Motto Science & Technology Co. Ltd
  • JH Nanhang Life Sciences Co.,Ltd.
  • Sichuan Tianhua Chemical Group Co. Ltd.
  • Thermo Fisher Scientific Inc.

Report Scope

In this report, the Global Povidone Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Povidone Market, By End-Use Application

  • Pharmaceutical
  • Food & Beverages
  • Personal Care & Cosmetics
  • Adhesives
  • Others

Povidone Market, By Sales Channel

  • Direct Sale
  • Indirect Sale

Povidone Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Povidone Market.

Available Customizations:

Global Povidone Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Povidone Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By End-Use Application (Pharmaceutical, Food & Beverages, Personal Care & Cosmetics, Adhesives, Others)
    • 5.2.2. By Sales Channel (Direct Sale, Indirect Sale)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Povidone Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By End-Use Application
    • 6.2.2. By Sales Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Povidone Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By End-Use Application
        • 6.3.1.2.2. By Sales Channel
    • 6.3.2. Canada Povidone Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By End-Use Application
        • 6.3.2.2.2. By Sales Channel
    • 6.3.3. Mexico Povidone Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By End-Use Application
        • 6.3.3.2.2. By Sales Channel

7. Europe Povidone Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By End-Use Application
    • 7.2.2. By Sales Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Povidone Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By End-Use Application
        • 7.3.1.2.2. By Sales Channel
    • 7.3.2. France Povidone Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By End-Use Application
        • 7.3.2.2.2. By Sales Channel
    • 7.3.3. United Kingdom Povidone Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By End-Use Application
        • 7.3.3.2.2. By Sales Channel
    • 7.3.4. Italy Povidone Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By End-Use Application
        • 7.3.4.2.2. By Sales Channel
    • 7.3.5. Spain Povidone Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By End-Use Application
        • 7.3.5.2.2. By Sales Channel

8. Asia Pacific Povidone Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By End-Use Application
    • 8.2.2. By Sales Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Povidone Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By End-Use Application
        • 8.3.1.2.2. By Sales Channel
    • 8.3.2. India Povidone Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By End-Use Application
        • 8.3.2.2.2. By Sales Channel
    • 8.3.3. Japan Povidone Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By End-Use Application
        • 8.3.3.2.2. By Sales Channel
    • 8.3.4. South Korea Povidone Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By End-Use Application
        • 8.3.4.2.2. By Sales Channel
    • 8.3.5. Australia Povidone Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By End-Use Application
        • 8.3.5.2.2. By Sales Channel

9. Middle East & Africa Povidone Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By End-Use Application
    • 9.2.2. By Sales Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Povidone Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By End-Use Application
        • 9.3.1.2.2. By Sales Channel
    • 9.3.2. UAE Povidone Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By End-Use Application
        • 9.3.2.2.2. By Sales Channel
    • 9.3.3. South Africa Povidone Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By End-Use Application
        • 9.3.3.2.2. By Sales Channel

10. South America Povidone Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By End-Use Application
    • 10.2.2. By Sales Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Povidone Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By End-Use Application
        • 10.3.1.2.2. By Sales Channel
    • 10.3.2. Colombia Povidone Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By End-Use Application
        • 10.3.2.2.2. By Sales Channel
    • 10.3.3. Argentina Povidone Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By End-Use Application
        • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Povidone Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ashland Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. BASF SE
  • 15.3. Boai NKY Pharmaceuticals Ltd
  • 15.4. Glide Chem Private Limited
  • 15.5. Hangzhou Motto Science & Technology Co. Ltd
  • 15.6. JH Nanhang Life Sciences Co.,Ltd.
  • 15.7. Sichuan Tianhua Chemical Group Co. Ltd.
  • 15.8. Thermo Fisher Scientific Inc.

16. Strategic Recommendations

17. About Us & Disclaimer